These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9225210)

  • 1. Effects of an HMG-CoA reductase inhibitor, pravastatin, and bile sequestering resin, cholestyramine, on plasma plant sterol levels in hypercholesterolemic subjects.
    Hidaka H; Kojima H; Kawabata T; Nakamura T; Konaka K; Kashiwagi A; Kikkawa R; Shigeta Y
    J Atheroscler Thromb; 1995; 2(1):60-5. PubMed ID: 9225210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
    Nguyen LB; Cobb M; Shefer S; Salen G; Ness GC; Tint GS
    J Lipid Res; 1991 Dec; 32(12):1941-8. PubMed ID: 1816322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high plant sterol-enriched diet and cholesterol absorption inhibitor, SCH 58235, on plant sterol absorption and plasma concentrations in hypercholesterolemic wild-type Kyoto rats.
    Batta AK; Xu G; Bollineni JS; Shefer S; Salen G
    Metabolism; 2005 Jan; 54(1):38-48. PubMed ID: 15562378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
    Eriksson M; Hådell K; Holme I; Walldius G; Kjellström T
    J Intern Med; 1998 May; 243(5):373-80. PubMed ID: 9651560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
    Jacob BG; Richter WO; Schwandt P
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):396-400. PubMed ID: 7504129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
    Nguyen LB; Salen G; Shefer S; Tint GS; Ruiz F
    Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A marked and sustained reduction in LDL sterols by diet and cholestyramine in beta-sitosterolemia.
    Parsons HG; Jamal R; Baylis B; Dias VC; Roncari D
    Clin Invest Med; 1995 Oct; 18(5):389-400. PubMed ID: 8529322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis.
    Hidaka H; Nakamura T; Aoki T; Kojima H; Nakajima Y; Kosugi K; Hatanaka I; Harada M; Kobayashi M; Tamura A
    J Lipid Res; 1990 May; 31(5):881-8. PubMed ID: 2380636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study.
    Jones PH; Farmer JA; Cressman MD; McKenney JM; Wright JT; Proctor JD; Berkson DM; Farnham DJ; Wolfson PM; Colfer HT
    Clin Cardiol; 1991 Feb; 14(2):146-51. PubMed ID: 1904333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
    Salen G; Kwiterovich PO; Shefer S; Tint GS; Horak I; Shore V; Dayal B; Horak E
    J Lipid Res; 1985 Feb; 26(2):203-9. PubMed ID: 3989379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
    Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study.
    Mannarino E; Pirro M; Cortese C; Lupattelli G; Siepi D; Mezzetti A; Bertolini S; Parillo M; Fellin R; Pujia A; Averna M; Nicolle C; Notarbartolo A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):84-90. PubMed ID: 18762410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father.
    Cobb MM; Salen G; Tint GS; Greenspan J; Nguyen LB
    Metabolism; 1996 Jun; 45(6):673-9. PubMed ID: 8637439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis.
    Miettinen TA
    Eur J Clin Invest; 1980 Feb; 10(1):27-35. PubMed ID: 6768564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal.
    Clifton PM; Noakes M; Sullivan D; Erichsen N; Ross D; Annison G; Fassoulakis A; Cehun M; Nestel P
    Eur J Clin Nutr; 2004 Mar; 58(3):503-9. PubMed ID: 14985690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.